and 3+ leukocyte esterase (scale of 0 to 4+ with urine strip), along with a white blood cell count > 30/high-power field, indicating pyuria. Notably, two blood cultures and a urine culture obtained on the second and third days of hospitalization, respectively, showed no growth, whereas PCR analysis of stool sample was positive for Salmonella. Abdominopelvic computed tomography showed no bowel wall thickening. On the fourth day, a stool culture was obtained and no colony was detected.
Two sets of blood culture bottles (BacT/Alert FA Plus and BacT/ Alert FN Plus; bioMérieux, Marcy-l'Étoile, France) were obtained on the fourth day and immediately incubated in a BacT/Alert 3D automated blood culture system (bioMérieux). After 24 hours, a specific colorimetric visual signal was detected in the BacT/Alert FN plus bottle. Subculture on MacConkey agar plate showed colorless, pale colonies of gram-negative rods ( Fig. 1A ). Matrixassisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) using VITEK MS (bioMérieux) and Bruker Biotyper (Bruker Daltonics, Bremen, Germany) identified Salmonella species (score ≥ 2.0) with 99% reliability. The isolate was identified as belonging to serogroup C with a polyvalent antisera kit (JoongKyeom, Ilsan, Korea). The TSI agar biochemical test results were as follows: alkaline, acid, gas-negative, H2S-negative ( Fig. 1B) . The isolate was sent to Research Institute of Public Health and the Environment, Seoul, Korea, to further identify the serotype, and Salmonella enterica serovar Infantis was confirmed.
Anti-microbial susceptibility of the isolate was determined by the automated broth microdilution method using VITEK 2 (bio-Mérieux). The isolate was resistant to cefazolin (minimal inhibitory concentration [MIC], 4 μg/mL), cefoxitin (MIC, 4 μg/mL), amikacin (MIC, 2 μg/mL), and gentamicin (MIC, 1 μg/mL). The patient was empirically treated with piperacillin/tazobactam and levofloxacin due to suspected urinary tract or gastrointestinal infection. Metronidazole and ciprofloxacin were administered based on the positive Salmonella PCR result. The blood culture on the eighth day of hospitalization was negative. However, ceftriaxone was administered because fever spiking persisted until discharge (February 2019).
Direct sequencing of the phs and cysJIH operons of the isolate was performed, and the sequences aligned to those of strain Salmonella enterica serovar Infantis FSIS1502916 (NZ_CP016408.1) using DNAman 6.0 (Lynnon, Quebec, Canada). The primers were as follows: cysJ1 forward 5´-CGGCATCGGACAGTTTACCT-3´ and reverse 5´-CTGGATGCTCAGGCGCTAAT-3´, cysJ2 forward 5´-GATTAGCGCCTGAGCATCCA-3´ and reverse 5´-CGTGTCGAT-GCTGACGTTGA-3´, cysJ3 forward 5´-TTCAACGTCAGCATCGA-CAC-3´ and reverse 5´-CTGCGTTTACTCACCCCAGT-3´, cysI1 forward 5´-CTCGCGGTATACCTTGCCTG-3´ and reverse 5´-CT-GCTGGAGATCGCGAAGAT-3´, cysI2 forward 5´-GCACGCTGGC-AATAATCAGG-3´ and reverse 5´-TGCATGCTGAAGCCTACGAA-3´, cysI3 forward 5´-CGATATCATTTTGCGGCGGG-3´ and reverse 5´-CGGTATGGACCTCGAATCGG-3´, cysH forward 5´-GCCGGAT-TTTTCATAGCAGCA-3´ and reverse 5´-CAGGCAAGGTATACCGC-GAG-3´, and previously reported primers for phs [10] . Unlike previous cases [10] , no point mutation was found in the coding region of the phs operon, whereas a nucleotide change (C to T) at the first base pair in the 3´-untranslated region of phsC was observed. In addition, a 1247A > G variant, causing the V416A missense mutation, was found in cysJ. This is the first report of a missense mutation in the cys gene in non-H2S-producing Sal- monella. However, further research is needed to determine whether these mutations influence H2S production or not.
Since the identification of Salmonella serotype is not possible in most clinical laboratories using conventional biochemical testing, non-H2S-producing Salmonella can be misdiagnosed as Salmonella Typhi or even other Enterobacteriaceae. Therefore, caution is needed with the diagnosis of Salmonella infection.
